Use of mannitol to obviate propranolol-induced myocardial depression in ischemic canine heart. 1980

G Kyriakidis, and M Barletta

To obviate the myocardial depressant action of propranolol, the use of this drug in combination with a positive inotropic agent, mannitol, was studied in the ischemic heart of the dog. Mannitol (25%) administered prior to propranolol augmented myocardial contractility, as shown by an upward shift of the relationship between the pressure change with time and the mean left atrial pressure. Subsequent administration of propranolol did not offset the positive inotropic response to mannitol whereas it markedly reduced the heart rate from a control ischemic value of 127.8 +/- 3.4 to 109 +/- 4.0 beats/min. The myocardial oxygen requirement, as determined by the tension-time index per minute, decreased 26.3 +/- 1.2% below the control ischemic value. These findings suggest that hypertonic mannitol augments contractility in the ischemic failing heart while sustaining the desirable negative chronotropic action of propranolol. This procedure may potentiate the beneficial effects of propranolol on the myocardial oxygen balance and serve as an effective therapeutic modality in the control of acute irreversible ischemia.

UI MeSH Term Description Entries
D006982 Hypertonic Solutions Solutions that have a greater osmotic pressure than a reference solution such as blood, plasma, or interstitial fluid. Hypertonic Solution,Solution, Hypertonic,Solutions, Hypertonic
D008297 Male Males
D008353 Mannitol A diuretic and renal diagnostic aid related to sorbitol. It has little significant energy value as it is largely eliminated from the body before any metabolism can take place. It can be used to treat oliguria associated with kidney failure or other manifestations of inadequate renal function and has been used for determination of glomerular filtration rate. Mannitol is also commonly used as a research tool in cell biological studies, usually to control osmolarity. (L)-Mannitol,Osmitrol,Osmofundin
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females

Related Publications

G Kyriakidis, and M Barletta
August 1979, Kardiologiia,
G Kyriakidis, and M Barletta
January 1973, The Journal of cardiovascular surgery,
G Kyriakidis, and M Barletta
April 1979, Pflugers Archiv : European journal of physiology,
G Kyriakidis, and M Barletta
April 1967, British medical journal,
G Kyriakidis, and M Barletta
May 1967, British medical journal,
G Kyriakidis, and M Barletta
July 2003, American heart journal,
G Kyriakidis, and M Barletta
February 1990, Vrachebnoe delo,
G Kyriakidis, and M Barletta
November 1982, [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai,
G Kyriakidis, and M Barletta
August 1969, The American journal of cardiology,
Copied contents to your clipboard!